Cargando…
Evaluation of antibody detection against the NDO-BSA, LID-1 and NDO-LID antigens as confirmatory tests to support the diagnosis of leprosy in Yunnan province, southwest China
Although multidrug therapy (MDT) has been widely used for the treatment of leprosy for nearly 40 y, the disease remains a public health concern in some areas. The early detection of leprosy cases is vital to interrupt Mycobacterium leprae transmission, but currently diagnosis is typically achieved d...
Autores principales: | Jian, Liu, Xiujian, Shang, Yuangang, You, Yan, Xing, Lianchao, Yuan, Duthie, Malcolm S, Yan, Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7092950/ https://www.ncbi.nlm.nih.gov/pubmed/31667502 http://dx.doi.org/10.1093/trstmh/trz089 |
Ejemplares similares
-
Identifying Leprosy and Those at Risk of Developing Leprosy by Detection of Antibodies against LID-1 and LID-NDO
por: Amorim, Francianne M., et al.
Publicado: (2016) -
Utility of immunoglobulin isotypes against LID-1 and NDO-LID for,
particularly IgG1, confirming the diagnosis of multibacillary
leprosy
por: Marçal, Pedro Henrique Ferreira, et al.
Publicado: (2018) -
Performance of serological tests PGL1 and NDO-LID in the diagnosis of leprosy in a reference Center in Brazil
por: Leturiondo, André Luiz, et al.
Publicado: (2019) -
Association between NDO-LID and PGL-1 for leprosy and class I and II human leukocyte antigen alleles in an indigenous community in Southwest Amazon
por: Teles, Stéfanie Ferreira, et al.
Publicado: (2020) -
Leprosy: prevalence and factors associated with seropositivity for anti-NDO-LID antibodies in children under 15 years of age
por: Gomes, Luciane Cardoso, et al.
Publicado: (2019)